The method for a skin treatment using a first snail on a human patient includes placing the first snail on a first surface to allow the first snail to attach itself to the first surface. The method further includes projecting a first predetermined amount of a first agent onto the first snail with to cause the first snail to secrete a liquid on the first surface. The method further includes administering the secreted liquid over a surface of a skin of a portion of a body of the human patient.

Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

Disclosed are applications of a mussel adhesive protein or preparations thereof in suppression of skin inflammations. Specifically disclosed are applications of a mussel adhesive protein, preparations thereof and applications thereof in dermatitis, eczema, skin ulcer, technologies related to burns (comprising skin grafting), perniones, surgical incisions, herpes, abrasions, scars, psoriasis, erythema multiforme, skin damage after radiotherapy, skin cancers, folliculitis, urticaria and drug eruption, and applications in sunburn, polymorphous light eruption, pathological alopecia (comprising hair transplant), acne vulgaris, rosacea (that is, acne rosacea), and the like, and applications in the treatment of otitis externa.

The invention provides an isolated extract comprising glycosaminoglycans from whelk and/or cockle species.

The invention provides an isolated extract comprising glycosaminoglycans from whelk and/or cockle species.

Disclosed is an antiviral composition having excellent antiviral activity against coronavirus and variant viruses thereof, more particularly, an antiviral composition containing an oyster shell powder; an Inonotus obliquus powder; and a silkworm powder or a Gryllus bimaculatus powder; as an active ingredients. The antiviral composition has activity of enhancing immunity that acts as an in-vivo defense against infection with harmful substances such as bacteria and viruses, and has activity of effectively inhibiting the proliferation of coronavirus, and thus has useful effects as a drug or health functional food for the prevention, amelioration or treatment of coronaviral infection.

Disclosed is an antiviral composition having excellent antiviral activity against coronavirus and variant viruses thereof, more particularly, an antiviral composition containing an oyster shell powder; an Inonotus obliquus powder; and a silkworm powder or a Gryllus bimaculatus powder; as an active ingredients. The antiviral composition has activity of enhancing immunity that acts as an in-vivo defense against infection with harmful substances such as bacteria and viruses, and has activity of effectively inhibiting the proliferation of coronavirus, and thus has useful effects as a drug or health functional food for the prevention, amelioration or treatment of coronaviral infection.

Disclosed is an antiviral composition having excellent antiviral activity against coronavirus and variant viruses thereof, more particularly, an antiviral composition containing an oyster shell powder; an Inonotus obliquus powder; and a silkworm powder or a Gryllus bimaculatus powder; as an active ingredients. The antiviral composition has activity of enhancing immunity that acts as an in-vivo defense against infection with harmful substances such as bacteria and viruses, and has activity of effectively inhibiting the proliferation of coronavirus, and thus has useful effects as a drug or health functional food for the prevention, amelioration or treatment of coronaviral infection.

An aerosol liposome of a marine extract and a method of producing the same are introduced. The marine extract is extracted from cell membranes of marine processing streams, including phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and lysophosphatidylcholine (LysoPC), further including at least phosphatidylserine (PS). The aerosol liposome is of a particle diameter of less than 2,000 nm. The surface of the aerosol liposome carries phosphatidylserine (PS) molecules. The aerosol liposome of a marine extract, thus provided, is simple and stable and can be absorbed through the mouth, nose, upper respiratory tract, and epidermis and engulfed by macrophages therein to quickly alleviate or regulate systematic inflammatory responses and prevent inflammation-related diseases.

An aerosol liposome of a marine extract and a method of producing the same are introduced. The marine extract is extracted from cell membranes of marine processing streams, including phosphatidylserine (PS), phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylinositol (PI), and lysophosphatidylcholine (LysoPC), further including at least phosphatidylserine (PS). The aerosol liposome is of a particle diameter of less than 2,000 nm. The surface of the aerosol liposome carries phosphatidylserine (PS) molecules. The aerosol liposome of a marine extract, thus provided, is simple and stable and can be absorbed through the mouth, nose, upper respiratory tract, and epidermis and engulfed by macrophages therein to quickly alleviate or regulate systematic inflammatory responses and prevent inflammation-related diseases.